ChemicalBook > CAS DataBase List > Torudokimab
Torudokimab
- Product Name
- Torudokimab
- CAS No.
- 2241728-76-5
- Chemical Name
- Torudokimab
- Synonyms
- Torudokimab;Torudokimab (anti-IL-33);Research Grade Torudokimab;Research Grade Torudokimab (DHB74003)
- CBNumber
- CB610617029
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Torudokimab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Torudokimab Chemical Properties,Usage,Production
Uses
Torudokimab is a humanized antibody expressed in CHO, targeting IL-33. Torudokimab has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Torudokimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
Torudokimab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Torudokimab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com
- Country
- China
- ProdList
- 1442
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 33175446423
- support@antibodysystem.com
- Country
- China
- ProdList
- 6739
- Advantage
- 58
- Tel
- 400-668-6834
- info@selleck.cn
- Country
- China
- ProdList
- 6071
- Advantage
- 58
- Tel
- 9785721070
- info@cellsciences.com
- Country
- China
- ProdList
- 6308
- Advantage
- 58
2241728-76-5, TorudokimabRelated Search:
Teropavimab
Gontivimab
Keliximab
Obiltoxaximab
Demupitamab
Crenezumab
Simridarlimab
Research Grade Clivatuzumab (DHD14205)
Research Grade Vandortuzumab (DHJ76001)
Etevritamab